WhyWeVax

We provide you and your family with research-backed resources on #vaccines so you can make informed decisions that will keep you healthy.

[WhyWeVax @WhyWeVax]

Check out the Why We Vax youtube channel for #COVIDvaccine facts, interviews with vaccinologists, and more information about our fight against misinformation. https://t.co/ELiboQsIVw #VaccinesSaveLives #vaccines #WhyWeVax

[Prof Peter Hotez MD PhD DSc(hon) @PeterHotez]

The awful consequences of measles infection versus the safety of the MMR vaccine

[WhyWeVax @WhyWeVax]

There you have it. First measles death… we said this was going to happen more and more…. https://t.co/WybitluuOA

[WhyWeVax @WhyWeVax]

@rdmorris @PeterHotez Agreed

[WhyWeVax @WhyWeVax]

Concerned about toxic misinformation? Check out Dr. Mike Miller’s new book, “Reversing Misinformation.” Details on the Kickstarter page, including videos and interviews: https://t.co/nK2cle0RVq . Learn more about Dr. Miller's expertise here: https://t.co/2IXmEJQ5fd

[WhyWeVax @WhyWeVax]

Latest article: "Kids' Health at Risk as Vaccination Rates Drop Worldwide," @axios highlights a troubling decline in global vaccination rates. Experts warn of potential disease resurgence. Read more: https://t.co/18owCY19BZ

[WhyWeVax @WhyWeVax]

In the latest article: "First Clinical Trial for Nasal COVID-19 Vaccine," @medeconomics highlights new vaccine developments and health updates. CDC notes changes in testing may skew disease data. Read more: https://t.co/dQsGKvfX2U #vaccinessaveslives

[WhyWeVax @WhyWeVax]

Latest article: "New Mid-Year Vaccine Recommendations Announced," @medscape reports on ACIP's updated guidelines for 2024, reflecting recent outbreaks and post-pandemic changes. Read more: https://t.co/rgbPcQgzWy
#vaccinessaveslives

[WhyWeVax @WhyWeVax]

Latest article: "New Mid-Year Vaccine Recommendations Announced," @medscape reports on ACIP's updated guidelines for 2024, reflecting recent outbreaks and post-pandemic changes. Read more: https://t.co/rgbPcQgzWy
#vaccinessaveslives

[WhyWeVax @WhyWeVax]

Latest from @nytimes: "Malaria Vaccine Delayed as Concerns Rise." Airfinity notes that post-pandemic changes may skew disease data. Read more: https://t.co/3cwSiGJZsD
#vaccinessaveslives

[WhyWeVax @WhyWeVax]

Latest news: "U.S. Government to Pay Moderna $176M to Develop mRNA Flu Vaccine" via @usnews. This new initiative boosts investment in advanced vaccine tech for better pandemic preparedness.

Read more: https://t.co/IjtQENEPzz

#VaccinesSaveLives

[WhyWeVax @WhyWeVax]

New clinical trial begins for next-gen nasal COVID-19 vaccine. Researchers aim for enhanced, longer-lasting protection by targeting mucosal immunity. Early studies look promising!

Read more: https://t.co/ORSUUFebxd

#vaccinessaveslives

[WhyWeVax @WhyWeVax]

In a new article, Health Day News reports that the CDC now recommends everyone over 6 months old get the updated COVID-19 vaccine to boost protection against new variants. Dr. Mandy Cohen emphasizes that vaccination is key to preventing severe outcomes.
https://t.co/2aqg0jkauP

[WhyWeVax @WhyWeVax]

Pfizer and BioNTech receive positive CHMP opinion for their new COVID-19 vaccine targeting the XBB.1.5 subvariant, aiming to enhance protection against new strains. More info: https://t.co/8RiPiZkF2D

[WhyWeVax @WhyWeVax]

In a recent article, @PharmaVoice discusses the hesitancy surrounding Moderna's new COVID-Flu combination vaccine. Concerns about effectiveness and public acceptance are being addressed by providing clear information and engaging with healthcare providers.
https://t.co/bMBalConuh

[WhyWeVax @WhyWeVax]

Analysis shows global infectious disease outbreaks are surging due to falling vaccination rates, decreased population immunity, and climate change. Enhanced surveillance and timely interventions are crucial to control the spread. More details here: https://t.co/8Mo7lMpFEN

[WhyWeVax @WhyWeVax]

French President Macron and African leaders are pushing for increased vaccination efforts in Africa following a recent polio outbreak. This initiative aims to strengthen healthcare and prevent future epidemics. Read more:https://t.co/h5YrXKGTOZ

[WhyWeVax @WhyWeVax]

The latest CDC report on COVID-19 highlights significant updates on vaccination rates, breakthrough cases, and trends in hospitalizations and deaths. Stay informed about the evolving situation to protect yourself and others.https://t.co/1UgzLIMkDQ

[WhyWeVax @WhyWeVax]

Check out Mike Miller’s Kickstarter campaign for his upcoming book “Reversing Misinformation: How to Help Your Family, Friends, Community and World.” https://t.co/nK2cle0RVq. Mike has been focusing on these issues during the pandemic and has terrific insights.

[WhyWeVax @WhyWeVax]

Novavax has submitted an application to the FDA for its updated protein-based COVID-19 vaccine formula for 2024-2025. This new formula aims to enhance protection against emerging variants. Stay tuned for updates! Read more:https://t.co/V14EVDYa4x

[WhyWeVax @WhyWeVax]

New study highlights that the HPV vaccine significantly reduces cancer risk in men. This is a major step forward in preventing HPV-related cancers. Stay protected and informed! Read more: https://t.co/vls8KBj0Tm